Microdosing and standard-dosing take-home buprenorphine from the emergency department: A feasibility study.
Jessica Moe, Katherin Badke, Megan Pratt...
https://pubmed.ncbi.nlm.nih.gov/33392580/Actively Recruiting
Led by University of British Columbia · Updated on 2026-03-12
7200
Participants Needed
1
Research Sites
22 weeks
Total Duration
Opioid poisoning is a major cause of preventable death and lost years of life in Canada, driven mainly by potent synthetic opioids like fentanyl. Emergency departments, which operate 247 and are frequently visited by people who use drugs, provide critical opportunities to treat opioid poisoning and initiate care. This observational study aims to create a nationwide Canadian Emergency Department Research Network CEDRN Opioid Registry to collect and harmonize data on patients presenting with opioid poisoning, opioid dependence, or polysubstance use across multiple sites. The goal is to generate evidence to guide clinical practice and develop a tool to predict risk of death within 60 days after an emergency visit. The study will identify patients of all ages presenting to emergency departments with suspected or confirmed opioid poisoning by screening electronic health records for specific diagnoses and medication orders related to opioids and opioid use disorder. Data collected will include patient demographics, clinical signs, treatments given in prehospital and hospital settings, and patient outcomes. The registry will capture the full patient journey from ambulance arrival to hospital discharge. Researchers will analyze variations in care and outcomes, assess safety and effectiveness of treatments such as naloxone and opioid agonist therapy, and develop a risk prediction rule to prioritize high-risk patients. Participants electronic health records will be reviewed and linked to administrative data to track outcomes such as retention on opioid agonist therapy and mortality at multiple time points up to 12 months. The study will monitor treatments like naloxone administration, hospital discharge status, and mortality. Knowledge users, patients with lived experience, and Indigenous advisors will help guide the research and dissemination of findings. The study plans to improve healthcare delivery, support health system sustainability, and inform clinical decision-making for patients with opioid poisoning nationwide.
CONDITIONS
CEDRN: Opioid Registry
J
Jeffrey P Hau, MSc
V
Vi Ho, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of British Columbia
Lead Sponsor
Canadian Institutes of Health Research (CIHR)
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 72 hours (usually within the first 3 days since arrival)
Participants who present to emergency departments with opioid poisoning or dependence are observed through their emergency department visit and hospital stay to collect data on treatments, clinical course, and outcomes.
Continuous observation during emergency department and hospital stay
Duration - Up to 12 months
Participants are followed up through administrative data linkages to assess retention on opioid agonist therapy and mortality at 30 and 60 days, and 3 and 12 months after their emergency department visit.
No in-person visits; data collected through administrative records
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Have more questions? Get in touch with our team for quick support
Jessica Moe, Katherin Badke, Megan Pratt...
https://pubmed.ncbi.nlm.nih.gov/33392580/Weiwei Beckerleg, Joel Hudgins
https://pubmed.ncbi.nlm.nih.gov/35302449/Valerie Mok, Callahan Brebner, Justin Yap...
https://pubmed.ncbi.nlm.nih.gov/38160902/Benedikt Fischer
https://pubmed.ncbi.nlm.nih.gov/36950034/Yanjin Chen, Yanbin Wang, Suzanne Nielsen...
https://pubmed.ncbi.nlm.nih.gov/32580113/Kathryn Hawk, Jason Hoppe, Eric Ketcham...
https://pubmed.ncbi.nlm.nih.gov/34172303/Tara Gomes, Sophie A Kitchen, Regan Murray
https://pubmed.ncbi.nlm.nih.gov/34037734/Tara Gomes, Tonya J Campbell, Sophie A Kitchen...
https://pubmed.ncbi.nlm.nih.gov/35230394/Jessica Moe, Mei Chong, Bin Zhao...
https://pubmed.ncbi.nlm.nih.gov/33731425/Janusz Kaczorowski, Jaunathan Bilodeau, Aaron M Orkin...
https://pubmed.ncbi.nlm.nih.gov/32557932/University of British Columbia
Lead Sponsor
Canadian Institutes of Health Research (CIHR)
Collaborating Sponsor